Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

June-16-99

Osteoporosis Drug Decreases Risk for Breast Cancer

According to a study published in The Journal of the American Medical Association, a new drug being tested to combat osteoporosis in premenopausal women has been found to simultaneously fight breast disease. An international study conducted in 180 American hospitals and 24 European health centers found that raloxifene reduced a womanís risk of contracting breast cancer by 76%.

The 3-year breast cancer study followed 7,705 women; 2,557 who received one tablet of raloxifene per day, 2,572 who took two raloxifene pills daily, and 2,576 women who took two placebo pills each day. All the women were under 81 years of age.

Results showed that of the women who received either dose of raloxifene (5,129 women), only 13 cases of breast cancer developed. This compares to 26 cases of breast cancer found in the women who took the dummy pills (2,576 women).

Researchers report that raloxifene "prevents estrogen-related breast cancers by occupying the same molecular receptor sites as the estrogen molecule on the surface of cells. [It] blocks estrogen's cancer promoting effects on breast and endometrial tissue . . ." Scientists are comparing this drug with tamoxifen, a similar drug that also obstructs estrogen on breast tissue.

Side effects of raloxifene included blood clots, hot flashes, flu symptoms, cramps, and swelling of the legs. The results of the study found no differences in the effectiveness of the drug in women who received one or two tablets of raloxifene daily. Currently, the study is continuing in order to examine the long-term effects and usefulness of raloxifene in preventing breast cancer.

Media Resources: New York Times - June 16, 1999


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

12/19/2014 Woman on Life Support Revives Ireland Abortion Debate - Debate surrounding Ireland's ban on abortion has come up again following a current case involving a woman who is being kept on life support because she is pregnant. The woman's family wants her to be taken off life support, but doctors refuse because Irish law says they must do what they can to protect the 16-week-old fetus. . . .
 
12/19/2014 DC City Council Unanimously Approves Reproductive Health Anti Discrimination Bill - Wednesday, the Washington, DC City Council unanimously passed a bill that will prohibit employer interference in the reproductive health decisions of their employees. The Reproductive Health Non-Discrimination Amendment Act of 2014 was first introduced by DC Councilmember David Grosso (I-At Large), just ahead of the Supreme Court's ruling in favor of for-profit retail chain Hobby Lobby this summer. . . .
 
12/19/2014 Incremental Gains for Women in Congress - When the 114th Congress is sworn into office on January 3rd, 2015, there will be exactly the same number of women in Senate as the year before, 20, and a record-high number of women in the US House, 84. . . .